Prelude Capital Management’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$89.5K Sell
2024
Q4
$277K Buy
2024
Q3
$145K Sell
2024
Q2
$253K Buy
2024
Q1
$277K Buy
2023
Q4
$78.4K Buy